Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - timolol maleate 6.8 mg/ml equivalent to timolol 5 mg/ml - eye drops, solution - 0.5% w/v - active: timolol maleate 6.8 mg/ml equivalent to timolol 5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - ethinylestradiol 0.0306mg; levonorgestrel 0.15mg - film coated tablet - 0.15mg/0.03mg - active: ethinylestradiol 0.0306mg levonorgestrel 0.15mg excipient: acacia disodium edetate   ethylcellulose lactose monohydrate macrogol 6000 magnesium stearate maize starch methyl hydroxybenzoate microcrystalline cellulose polacrilin potassium purified talc sucrose   titanium dioxide calcium carbonate carnauba wax glycerol iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   purified water sucrose titanium dioxide - oral contraception

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - risperidone 0.5mg;   - film coated tablet - 0.5 mg - active: risperidone 0.5mg   excipient: colloidal silicon dioxide hypromellose iron oxide red lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc   sodium laurilsulfate titanium dioxide - treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness),and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - risperidone 1mg;   - film coated tablet - 1 mg - active: risperidone 1mg   excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc   sodium laurilsulfate - treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness),and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - risperidone 2mg;   - film coated tablet - 2 mg - active: risperidone 2mg   excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc   sodium laurilsulfate sunset yellow fcf titanium dioxide - treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness),and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - risperidone 3mg;   - film coated tablet - 3 mg - active: risperidone 3mg   excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc   quinoline yellow sodium laurilsulfate titanium dioxide - treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness),and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - risperidone 4mg;   - film coated tablet - 4 mg - active: risperidone 4mg   excipient: colloidal silicon dioxide hypromellose indigo carmine lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc   quinoline yellow sodium laurilsulfate titanium dioxide - treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness),and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - risperidone 6mg;   - film coated tablet - 6 mg - active: risperidone 6mg   excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc   quinoline yellow sodium laurilsulfate sunset yellow fcf titanium dioxide - treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness),and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 111.9mg ((form-i) equivalent to 100mg sertraline);  ;  ;   - film coated tablet - 100 mg - active: sertraline hydrochloride 111.9mg ((form-i) equivalent to 100mg sertraline)       excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 purified water sodium starch glycolate titanium dioxide - arrow - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 55.95mg ((form-i) equivalent to 50mg sertraline);  ;  ;   - film coated tablet - 50 mg - active: sertraline hydrochloride 55.95mg ((form-i) equivalent to 50mg sertraline)       excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 purified water sodium starch glycolate titanium dioxide - arrow - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.